SEARCH RESULTS FOR: ("ios永久免签(TG bot:搜wap2bot).vts")(1072 results)

4.1mm Diameter, 4.8mm Platform TG Implant Length 12mm RBM Collar Height 1.8mm

4.1mm Diameter, 4.8mm Platform TG Implant Length 10mm Sandblast Collar Height 1.8mm

4.1mm Diameter, 4.8mm Platform TG Implant Length 8mm RBM Collar Height 1.8mm

3.3mm Diameter, 4.8mm Platform TG Implant Length 14mm Sandblast Collar Height 1.8mm

3.3mm Diameter, 4.8mm Platform TG Implant Length 14mm RBM Collar Height 1.8mm

3.3mm Diameter, 4.8mm Platform TG Implant Length 12mm Sandblast Collar Height 1.8mm

3.3mm Diameter, 4.8mm Platform TG Implant Length 12mm RBM Collar Height 1.8mm

3.3mm Diameter, 4.8mm Platform TG Implant Length 10mm Sandblast Collar Height 1.8mm

3.3mm Diameter, 4.8mm Platform TG Implant Length 10mm RBM Collar Height 1.8mm

3.3mm Diameter, 4.8mm Platform TG Implant Length 8mm Sandblast Collar Height 1.8mm

3.3mm Diameter, 4.8mm Platform TG Implant Length 8mm RBM Collar Height 1.8mm

Scan Body with Screw Compatible with Astra Tech OsseoSpeed 3.5/4.0 IOS

Stethee Pro Mobile iOS Application is a component of the Stethee Pro Software System. The Stethee Pro Software System is intended for use with the Stethee Pro Electronic Stethoscope.

No Description

No Description

reSET-O® Mobile Application running on iOS. reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic.

reSET® Mobile Application running on iOS. reSET is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12 week (90 days) prescription-only treatment for patients with substance use disorder (SUD), who are not currently on opioid replacement therapy, who do not abuse alcohol solely, or who do not abuse opioids as their primary substance of abuse. It is intended to: - increase abstinence from a patient’s substances of abuse during treatment, and - increase retention in the outpatient treatment program.

No Description

Eversense 365 Mobile Application for iOS is a software application that runs on a mobile device (e.g., smart phone or tablet) and displays glucose data, trend information, and alerts.

Eversense CGM Mobile Application (iOS) is a software application that runs on a mobile device (e.g., smartphone or tablet) and displays glucose data, trend information, and alerts.

Eversense CGM Mobile Application (iOS) is a software application that runs on a mobile device (e.g., smartphone or tablet) and displays glucose data, trend information, and alerts.

Eversense CGM Mobile Application (iOS) is a software application that runs on a mobile device (e.g., smartphone or tablet) and displays glucose data, trend information, and alerts.

DRUGS OF ABUSE 1

BENZOYLECGONINE 1

MORPHINE PLUS

An iOS mobile application used to adjust Sonify Hearing wireless OTC hearing aids.

An iOS platform mobile application used to adjust NoviMed wireless OTC hearing aids.

TG Ab QC Kit - Atellica IM - CLT 2 x 3 x 2.0 mL

TG Ab - Atellica IM - Master Curve Material Kit 6 x 1 x 1.0mL

No Description

No Description

No Description

No Description

Care Assist

myDigitalKnee mobile app is used with a Digital Knee sensor attached to a brace or orthosis and worn by a patient to collect motion data and assist with management of their condition.

Software as a Medical Device (SaMD) which operates as a medication reminder and support services; Operates on Apple iOS devices.

actiTENS is a transcutaneous electrical nerve stimulation (TENS) medical device designed to manage chronic pain. The compact design and flexible shape of the actiTENS electrical impulse generator allows to fix it for daily use directly to the body of the patient. The impulse generator is delivered with a separate cradle which allows safely recharging its non- removable battery. The actiTENS is compatible with a selection of disposable electrodes and compatible connector cables transmit the electrical stimulation impulses to the targeted nerves according to the selected therapy. The electrical stimulation waveforms are biphasic and asymmetric. The actiTENS is controlled via a downloadable mobile app which allows the comfortable and simple selection of the adequate stimulation program. The actiTENS is intended to be used by the patient at home and also for therapeutic application by medical professionals. It is available for prescription only.

No Description

No Description

No Description

Compatible with Dentsply Sirona XiVE MP _ TG Consisting of: 1x Screw for impression copings

Compatible with Dentsply Sirona XiVE MP _ TG Consisting of: 1x Screw for impression copings

Compatible with Dentsply Sirona XiVE MP _ TG Consisting of: 1x Screw for impression copings

Compatible with Dentsply Sirona XiVE MP _ TG Consisting of: 1x Screw for impression copings

Thyreoglobulin - IMMULITE - CONS - 3x2mL

Thyreoglobulin - IMMULITE - RGT - 200 Tests

No Description

Accessories

Eversense NOW Remote Monitoring mobile application (iOS) is intended to be a secondary device used to remotely view an Eversense CGM System user’s glucose information.

A native iOS and Android mobile application also compatible with iPad. It is used to: • Locate patients according to patient ID • Locate scheduled procedures by connecting to modality worklist • Capture videos, images and audio files to be included in the study case. • Add notes and tags to each file (asset). • Upload any file to the Orpheus System • Manually or automatically delete files from the file library